Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.67
$0.393.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -74.45% | -65.72% | -48.97% | 9.85% | 18.46% |
| Total Depreciation and Amortization | -47.18% | -30.35% | -15.40% | -8.27% | -11.13% |
| Total Amortization of Deferred Charges | -100.00% | -89.36% | -74.35% | -51.94% | -29.95% |
| Total Other Non-Cash Items | 83.90% | 188.20% | 100.24% | 2.11% | -14.39% |
| Change in Net Operating Assets | 234.27% | -399.45% | -529.79% | -236.20% | -138.74% |
| Cash from Operations | -61.45% | -92.41% | -73.56% | -15.77% | 1.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 153.68% | 131.30% | 92.73% | -440.36% | -423.09% |
| Cash from Investing | 153.68% | 131.30% | 92.73% | -440.36% | -423.09% |
| Total Debt Issued | -- | -- | -- | -- | -79.66% |
| Total Debt Repaid | 100.00% | -44.75% | -143.13% | -376.75% | -569.16% |
| Issuance of Common Stock | -98.43% | -75.40% | -32.91% | 87,857.00% | 87,857.00% |
| Repurchase of Common Stock | 82.43% | 91.56% | 91.56% | 91.56% | 7.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -98.28% | -81.97% | -42.24% | 6,004.93% | 24,258.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.51% | -123.75% | -29.23% | 205.95% | 784.07% |